Of note, the expression levels of these immune checkpoint molecules were generally comparable in CD8+ Tdysfunctional cells in HNSCC12 (data not shown), suggesting distinctive features of dysfunctional T cells in NPC TME compared to those in other head and neck cancers. This evidence concerns the gene CD8A and head and neck cancer.